AssayIndex
Reports by quarter

Reports submitted in 2024-Q2 · page 2

First quarter of live submission. Median purity for the quarter is 99.10 % area, n=287. Read the 2024-Q2 state-of-the-index report →

287 records8 pagesmedian on this page 98.95 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-004907BPC-157ERPERP-2402-D9383PeptideMeter2024-Q299.177.0491.6Buyer-sourced0PASS
AX-2024-004821TirzepatideSWBSWB-2311-B7511Janoshik2024-Q297.687.2899.5Supplier-supplied0PASS
AX-2024-004665TirzepatideTFCTFC-2312-P3229Kestrel2024-Q298.332.91—Buyer-sourced0PASS
AX-2024-004265RetatrutideQYBQYB-2312-K4892PeptideMeter2024-Q298.204.67—Buyer-sourced0PASS
AX-2024-004189Kisspeptin-10WWBWWB-2311-T3203Janoshik2024-Q299.926.38—Buyer-sourced0PASS
AX-2024-005196GHRP-6CPCCPC-2401-N1934Janoshik2024-Q299.725.13102.2Buyer-sourced1MARGINAL
AX-2024-005374L-Glutathione (reduced)PPGPPG-2312-C7508Janoshik2024-Q299.748.06—Buyer-sourced0PASS
AX-2024-005150TirzepatideSGNSGN-2401-K9783PeptideMeter2024-Q298.223.9297.1Buyer-sourced0PASS
AX-2024-004679SemaglutideHomopeptideHOMO-2401-R3356VendorInvestigate2024-Q298.792.13—Buyer-sourced0PASS
AX-2024-004634AOD-9604TFCTFC-2402-L2242Janoshik2024-Q299.115.36—Buyer-sourced0PASS
AX-2024-005157TirzepatideSGNSGN-2401-K9783VendorInvestigate2024-Q297.834.30107.5Buyer-sourced0PASS
AX-2024-005084IGF-1 DES (1-3)SSASSA-2403-F6772Janoshik2024-Q298.514.1798.0Buyer-sourced0PASS
AX-2024-004975SemaglutideMKMMKM-2403-C4617PeptideMeter2024-Q298.735.2197.0Buyer-sourced0PASS
AX-2024-005376L-Glutathione (reduced)PPGPPG-2312-C7508PeptideMeter2024-Q299.167.7989.3Buyer-sourced1MARGINAL
AX-2024-004978SemaglutideMKMMKM-2403-C4617Janoshik2024-Q298.475.9692.1Buyer-sourced0PASS
AX-2024-004497CJC-1295 (no DAC)HYBHYB-2405-B6705VendorInvestigate2024-Q298.774.7690.4Buyer-sourced0PASS
AX-2024-004192Kisspeptin-10WWBWWB-2311-T3203Janoshik2024-Q299.935.79101.4Buyer-sourced0PASS
AX-2024-005386RetatrutidePPGPPG-2311-F8058PeptideMeter2024-Q298.394.2190.8Buyer-sourced0PASS
AX-2024-005080IGF-1 DES (1-3)SSASSA-2403-F6772Janoshik2024-Q299.064.3199.0Buyer-sourced0PASS
AX-2024-004784RetatrutideHomopeptideHOMO-2311-R5976Medutest2024-Q297.933.67—Buyer-sourced0PASS
AX-2024-004444SemaglutideGSPGSP-2405-W3331Medutest2024-Q298.873.2991.0Buyer-sourced0PASS
AX-2024-005333BPC-157SIGSIG-2405-6205Janoshik2024-Q298.795.8499.6Buyer-sourced0PASS
AX-2024-005024SermorelinKPKP-2312-R5133Kestrel2024-Q299.117.57—Buyer-sourced1FAIL
AX-2024-004822TirzepatideSWBSWB-2311-B7511Nordanalyt2024-Q297.336.6594.8Buyer-sourced0PASS
AX-2024-004786L-CarnosineHomopeptideHOMO-2405-P5405VendorInvestigate2024-Q299.306.6793.5Buyer-sourced0PASS
AX-2024-004231SemaglutideQYBQYB-2311-U4037Janoshik2024-Q299.723.71—Buyer-sourced1MARGINAL
AX-2024-005081IGF-1 DES (1-3)SSASSA-2403-F6772Janoshik2024-Q299.123.35100.0Laboratory-retained0PASS
AX-2024-004977SemaglutideMKMMKM-2403-C4617Kestrel2024-Q299.036.4092.1Buyer-sourced0PASS
AX-2024-004827TirzepatideSWBSWB-2311-B7511Janoshik2024-Q298.066.5394.6Supplier-supplied0PASS
AX-2024-004777RetatrutideHomopeptideHOMO-2311-R5976Medutest2024-Q297.983.3897.0Buyer-sourced1MARGINAL
AX-2024-004668TirzepatideTFCTFC-2312-P3229VendorInvestigate2024-Q298.483.4693.9Buyer-sourced0PASS
AX-2024-004440SemaglutideGSPGSP-2405-W3331PeptideMeter2024-Q299.482.9994.2Buyer-sourced0PASS
AX-2024-004251SermorelinQYBQYB-2404-W4423VendorInvestigate2024-Q299.933.5396.9Buyer-sourced0PASS
AX-2024-005392RetatrutidePPGPPG-2311-F8058Kestrel2024-Q299.934.35—Buyer-sourced0PASS
AX-2024-005149TirzepatideSGNSGN-2401-K9783Janoshik2024-Q298.194.14—Buyer-sourced0PASS
AX-2024-005045LL-37SSASSA-2403-V6369Janoshik2024-Q298.512.50107.1Buyer-sourced0PASS
AX-2024-004905BPC-157ERPERP-2402-D9383Janoshik2024-Q299.036.5293.6Buyer-sourced0PASS
AX-2024-004790L-CarnosineHomopeptideHOMO-2405-P5405Janoshik2024-Q299.866.21—Buyer-sourced0PASS
AX-2024-004637AOD-9604TFCTFC-2402-L2242Janoshik2024-Q299.195.09—Buyer-sourced1MARGINAL
AX-2024-004804BPC-157HJHJ-2402-M6198Medutest2024-Q299.554.31—Buyer-sourced0PASS